良性前列腺增大患者解除梗阻后储尿症状改善的评估及影响因素
研究纳入75例接受经尿道前列腺电切术(TURP)的良性前列腺增大患者,术前及术后6个月评估储尿症状改善及相关影响因素。结果显示,储尿症状持续者年龄更大、终末段逼尿肌过度活动比例更高、最大尿流率更高,而储尿症状缓解者IPSS评分更高、最大膀胱测压容量更大;结论认为高龄、最大膀胱测压容量小于250 mL及终末段逼尿肌过度活动与术后储尿症状持续相关。
要点
- 储尿症状持续者年龄显著大于缓解者(70.43±8.32岁 vs 67.04±7.49岁,P=0.022)。
- 最大膀胱测压容量在储尿症状缓解者显著高于持续者(345.18±90.89 mL vs 242.16±72.73 mL,P=0.001)。
- 终末段逼尿肌过度活动在储尿症状持续者中比例更高(26.3% vs 8.9%)。
核心结论
- 高龄、最大膀胱测压容量小于250 mL及终末段逼尿肌过度活动与TURP术后储尿症状持续和较差结局相关。
研究设计与样本
- 研究纳入2017年8月至2019年11月期间75例有TURP指征的患者,术前及术后6个月通过IPSS、生活质量评分、OABSS(Blaivas 2007)及尿动力学检查进行评估。
主要发现
- 储尿症状持续者年龄显著大于缓解者(70.43±8.32岁 vs 67.04±7.49岁,P=0.022)。
- IPSS评分在储尿症状缓解者显著更高(26.83±3.91 vs 24.35±3.68,P=0.017)。
- 终末段逼尿肌过度活动在储尿症状持续者中为26.3%,在缓解者中为8.9%。
- 最大尿流率在储尿症状持续者中为8.1,在缓解者中为6。
- 最大膀胱测压容量在储尿症状缓解者显著高于持续者(345.18±90.89 mL vs 242.16±72.73 mL,P=0.001)。
关键数值与推荐
- 储尿症状持续者与缓解者相比:年龄70.43±8.32岁 vs 67.04±7.49岁(P=0.022)。
- 储尿症状缓解者与持续者相比:IPSS评分26.83±3.91 vs 24.35±3.68(P=0.017)。
- 储尿症状持续者与缓解者相比:终末段逼尿肌过度活动26.3% vs 8.9%,最大尿流率8.1 vs 6。
- 储尿症状缓解者与持续者相比:最大膀胱测压容量345.18±90.89 mL vs 242.16±72.73 mL(P=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the improvement of storage symptoms in accordance with voiding symptoms and assess the prognostic factors that influence the relief of storage symptoms after transurethral resection of the prostate (TURP). METHODS: Between August 2017 and November 2019, 75 patients indicated for TURP were included in the study, we assessed the improvement of storage symptoms and factors that may influence storage symptoms persistence after TURP such as Age, Overactive bladder symptoms (OABS) score (Blaivas 2007) and Urodynamic parameters such as maximum flow rate (Q MAX), maximum cystometric capacity (MCC), bladder contractility index (BCI), phasic and terminal detrusor overactivity (DO). Assessment of patients was done before and 6 months after TURP by international prostate symptom score (IPSS), quality of life score (QLSS), OABSS (Blaivas score 2007), and urodynamic studies. RESULTS: Mean age of the patients was 67.88±7.82 years. The patients with persistence of storage symptoms were significantly older 70.43±8.32 vs 67.04±7.49 respectively P-value = 0.022, also IPSS score was significantly higher in patients with resolution of symptoms (26.83±3.91 vs 24.35±3.68 P = .017). Terminal D.O and Q max were significantly higher in patients with persistence of storage symptoms (26.3% and 8.1 vs 8.9% and 6 respectively). MCC was significantly higher in a patient with resolution vs persistence of storage symptoms (345.18±90.89 mL vs 242.16±72.73) respectively P = 0.001 There was no significant difference between both groups regarding duration of symptoms, prostate size, prostatic specific antigen (PSA), QOL score, OABS score, and maximum detrusor pressure CONCLUSION: more elderly patients with MCC less than 250 ccs and terminal DO were associated with worse outcomes and persistence of storage symptoms post TURP.
引用
- Gharib T, Eldakhakhny A, Alazaby H, et al. Evaluation of Storage Symptoms Improvement and Factors Affecting, After Relief of Obstruction in Patients With Benign Prostatic Enlargement. Urology. 2022. PMID: 35853509. doi:10.1016/j.urology.2022.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。